• 1
    Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD 1998 Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338:853860.
  • 2
    Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA 1998 A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51F58.
  • 3
    Lipsky JJ 1998 Abnormal fat accumulation in patients with HIV-1 infection. Lancet 351:847848.
  • 4
    Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE 2000 Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS 14:F63F67.
  • 5
    Orwoll ES 1998 Osteoporosis in men. Endocrinol Metab Clin North Am 27:349367.
  • 6
    Bilezikian JP 1999 Osteoporosis in men. J Clin Endocrinol Metab 84:34313434.
  • 7
    Moore AL, Vashisht A, Sabin CA, Mocroft A, Madge S, Phillips AN, Studd JW, Johnson MA 2001 Reduced bone mineral density in HIV-positive individuals. AIDS 15:17311733.
  • 8
    Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S 2001 Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS 15:975982.
  • 9
    Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:36663672.
  • 10
    Pinheiro JC, Bates DM 1999 Lme and nlme: Mixed-Effects Methods and Classes for S and S-PLUS Version 30 Bell Labs. Lucent Technologies and University of Wisconsin, Madison, WI.
  • 11
    Carr A, Miller J, Eisman JA, Cooper D 2001 Asteopenia in HIV-infected men: Association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy. AIDS 15:703709.
  • 12
    Guaraldi G, Ventura P, Albuzza M, Orlando G, Bedini A, Amorico G, Esposito R 2001 Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS 15:137138.
  • 13
    McDermott AY, Shevitz A, Knox T, Roubenoff R, Kehayias J, Gorbach S 2001 Effect of highly active antiretroviral therapy on fat, lean, and bone mass in HIV-seropositive men and women. Am J Clin Nutr 74:679686.
  • 14
    Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S 2001 Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS 15:12751280.
  • 15
    Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P 2003 Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis 36:482490.
  • 16
    Aukrust P, Haug CJ, Ueland T, Lien E, Muller F, Espevik T, Bollerslev J, Froland SS 1999 Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: Indication of normalization of the bone-remodeling process during highly active antiretroviral therapy. J Clin Endocrinol Metab 84:145150.
  • 17
    Jain RG, Lenhard JM 2002 Select HIV protease inhibitors alter bone and fat metabolism ex vivo. J Biol Chem 277:1924719250.
  • 18
    Kuhne CA, Heufelder AE, Hofbauer LC 2001 Bone and mineral metabolism in human immunodeficiency virus infection. J Bone Miner Res 16:29.
  • 19
    Christeff N, Melchior JC, de Truchis P, Perronne C, Nunez EA, Gougeon ML 1999 Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: Correlation between dyslipidaemia and steroid hormone alterations. AIDS 13:22512260.
  • 20
    Helle SI, Ueland T, Ekse D, Froland SS, Holly JM, Lonning PE, Aukrust P 2001 The insulin-like growth factor system in human immunodeficiency virus infection: Relations to immunological parameters, disease progression, and antiretroviral therapy. J Clin Endocrinol Metab 86:227233.
  • 21
    Kurland ES, Chan FK, Rosen CJ, Bilezikian JP 1998 Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J Clin Endocrinol Metab 83:25762579.
  • 22
    Dalgleish AG 1993 Immunobiological aspects of HIV treatment. Curr Opin Immunol 5:608614.
  • 23
    Fauci AS 1996 Host factors and the pathogenesis of HIV-induced disease. Nature 384:529534.
  • 24
    Goldring SR, Goldring MB 1996 Cytokines and skeletal physiology. Clin Orthop 324:1323.
  • 25
    Cohen-Solal ME, Boitte F, Bernard-Poenaru O, Denne MA, Graulet AM, Brazier M, de Vernejoul MC 1998 Increased bone resorbing activity of peripheral monocyte culture supernatants in elderly women. J Clin Endocr Metab 83:16871690.
  • 26
    Rodan GA 1998 Control of bone formation and resorption: Biological and clinical perspective. J Cell Biochem 31(Suppl):5561.
  • 27
    Fairfield WP, Finkelstein JS, Klibanski A, Grinspoon SK 2001 Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome. J Clin Endocrinol Metab 86:20202026.